companydata.dkBILLEV PHARMA ApS: Financial statements 2023
CVR: 81814813
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 29,072,533 and a net result of DKK 4,943,056 compared with DKK 6,013,157 the year before. That is a decrease of 3.6% compared with the year before. Equity amounted to DKK 5,263,056. The solvency ratio was 58.8%. The company had 21 employees in the financial year.
- Gross Profit
- 29,072,533 kr.
- Profit/Loss
- 4,943,056 kr.
- Equity
- 5,263,056 kr.
- Total Assets
- 8,946,496 kr.
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 29.1 mio. | 4.9 mio. | 5.3 mio. | 21 |
| 2022 | - | 30.2 mio. | 6 mio. | 6.3 mio. | 21 |
| 2021 | - | 25.6 mio. | 5.5 mio. | 5.9 mio. | 19 |
| 2020 | - | 21.4 mio. | 3.8 mio. | 4.1 mio. | 16 |
| 2019 | - | 17.5 mio. | 2.5 mio. | 2.8 mio. | 14 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity amounted to DKK 10,525,639.